Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
96.94
-0.99 (-1.01%)
At close: Oct 2, 2026, 4:00 PM EDT
96.99
+0.05 (0.05%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $1.43 billion as of October 2, 2026. Its market cap has increased by 190.01% in one year.
Market Cap
1.43B
Enterprise Value
1.48B
1-Year Change
190.01%
Ranking
Category
Stock Price
$96.94
ChartMarket Cap Chart
Since May 29, 2024, Inhibrx Biosciences's market cap has increased from $198.24M to $1.43B, an increase of 620.08%. That is a compound annual growth rate of 132.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 1.43B | 24.24% |
| Dec 31, 2025 | 1.15B | 415.39% |
| Dec 31, 2024 | 222.93M | 12.46% |
| May 29, 2024 | 198.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innoviva | 1.48B |
| Maze Therapeutics | 1.48B |
| AnaptysBio | 1.45B |
| Nanobiotix | 1.45B |
| Hemab Therapeutics Holdings | 1.45B |
| Ultragenyx Pharmaceutical | 1.45B |
| Tyra Biosciences | 1.44B |
| Ascentage Pharma Group International | 1.44B |